NeoGenomics Acquires Human Longevity - Oncology Division
NeoGenomics acquired Human Longevity - Oncology Division for $37.0M. View deal terms, timeline, and press on Fsome.
Deal Details
- Acquirer
- NeoGenomics
- Acquired Company
- Human Longevity - Oncology Division
- Price
- $37.0M
- Acquisition Type
- Acquisition
- Announced
- January 10, 2020
Canonical: https://fsome.com/acquisitions/neogenomics-acquires-human-longevity-oncology-division-8239985 · For the full deal terms, timeline, and press references, please enable JavaScript.